Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
8
×
boston blog main
boston top stories
8
×
life sciences
national blog main
national top stories
new york blog main
san francisco blog main
san diego blog main
san francisco top stories
clinical trials
indiana blog main
new york top stories
raleigh-durham blog main
san diego top stories
seattle blog main
boston
boulder/denver blog main
boulder/denver top stories
cancer
deals
detroit blog main
detroit top stories
fda
indiana top stories
national
novartis
raleigh-durham top stories
seattle top stories
texas blog main
texas top stories
venture capital
wisconsin blog main
wisconsin top stories
amgen
investing
medicare
merck
pfizer
roche
What
patients
8
×
bio
drug
market
medicine
roundup
fda
million
startup
acquisitions
advantages
ago
albert
alnylam
analytics
approve
awaits
bar
becker
benefiting
beta
biggest
billions
biofourmis
biological
bionics
blood
boston
bourla
brings
cancer
ceo
closed
coming
company
crispr
crossed
data
decades
decision
Language
unset
unknown
Current search:
patients
×
" boston top stories "
×
biotech
×
@xconomy.com
3 years ago
Biofourmis Hauls In $100M to Scale Digital Therapeutics Globally
@xconomy.com
4 years ago
Eisai Pulls Weight Loss Drug From Market After FDA Flags Cancer Risks
@xconomy.com
4 years ago
Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone
@xconomy.com
4 years ago
Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More
@xconomy.com
4 years ago
Bio Roundup: Michael Becker, Suzanne Eaton, Gene Therapy Moves & More
@xconomy.com
5 years ago
Laurie Glimcher To Headline Xconomy Keynote Series in Boston in September
@xconomy.com
5 years ago
Beta Bionics Secures $63M as AI-Driven “Pancreas” Heads to Key Tests
@xconomy.com
5 years ago
Patients Have “Fingers Crossed” As Alnylam Awaits Historic FDA Decision